AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Venlasys 37.5 Capsule ER

Prescription Icon
Prescription Required

Marketer

Neosys Medicare

Salt Composition

Venlafaxine (37.5mg)

Overview Venlasys 37.5 Capsule ER

Desvenlafaxine extended-release 37.5 mg capsules are indicated for managing depressive and anxiety disorders. This medication modifies brain chemistry, alleviating anxiety symptoms such as agitation, hyperactivity, impaired concentration, tiredness, perspiration, tachycardia, and intrusive or rapid thoughts. Administer Desvenlafaxine with food, consistently at the same time daily for optimal blood levels. If a dose is missed, take it immediately upon recall. Complete the prescribed course, even with symptom improvement, and avoid abrupt cessation, which may exacerbate symptoms. Common side effects include queasiness, emesis, sleep disturbances, reduced appetite, nervousness, bowel irregularity, hyperhidrosis, and sexual difficulties. Drowsiness and dizziness are possible; avoid activities requiring alertness until the drug's effects are known. These effects are generally transient and self-limiting. Consult your physician if they persist or are troublesome. Prior to commencing Desvenlafaxine, disclose any renal, cardiac, or hepatic impairment, or history of seizures. Report any unusual mood shifts, worsening depression, or suicidal ideation to your doctor immediately.

Primary Ingredients of Venlasys 37.5 Capsule ER

No text provided to rephrase.

Uses of Venlasys 37.5 Capsule ER

Mood disorders encompassing depressive and anxiety symptoms

Major Benefits of Venlasys 37.5 Capsule ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire capsule without chewing, crushing, or breaking it. Venlasys 37.5 ER Capsules should be taken with a meal.

Common Side effects of Venlasys 37.5 Capsule ER:

  • Nausea
  • Vomiting
  • Dizziness
  • Insomnia (difficulty in sleeping)
  • Decreased appetite
  • Anxiety
  • Constipation
  • Increased sweating
  • Sexual dysfunction

How to use Venlasys 37.5 Capsule ER:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the capsule whole; avoid crushing, chewing, or breaking it. Venlasys 37.5mg Extended-Release Capsules should be taken with a meal.

How Venlasys 37.5 Capsule ER works:

Venlasys 37.5 Extended-Release Capsules elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Venlasys 37.5 mg extended-release capsules.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Venlasys 37.5 mg capsules may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Venlasys 37.5 mg capsules are likely unsuitable for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant. Close observation of newborns for drowsiness and appropriate weight increase is recommended.

DrivingDrivingUNSAFE

Driving ability may be impaired by Venlasys 37.5 Capsule ER, due to potential side effects including dizziness, confusion, and visual disturbances like blurred vision.

KidneyKidneyCAUTION

Extended-release Venlasys 37.5mg capsules require careful administration for individuals with impaired kidney function. Dosage modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Extended-release Venlasys 37.5mg capsules require careful administration for individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Venlasys 37.5 Capsule ER :

Should you forget a Venlasys 37.5mg extended-release capsule, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Venlasys 37.5 Capsule ER

LabelValue
Chemical Type Anisole-based Compound
Developing Habits No.
Treatment Category Neuroscience of the Central Nervous System
Action Class SNRIs (serotonin-norepinephrine reuptake inhibitors)

FAQs on Venlasys 37.5 Capsule ER

Venlasys 37.5 Capsule ER may cause drowsiness. Inform your doctor about all other sleep aids you're taking before beginning treatment.
Yes. Venlafaxine ER 37.5 mg capsules are a psychotropic medication; psychotropic drugs are those affecting mood, behavior, and mental processes.
Venlafaxine ER 37.5mg capsules are not narcotics. Narcotics are opioid-derived drugs, such as heroin and morphine, known for their sedative effects.
Venlafaxine 37.5 mg ER and XR capsules are the same medication; both are extended-release formulations, delivering a steady medication level over time. Extended-release tablets reduce the frequency of dosing.
Taking mirtazapine with Venlafaxine ER 37.5mg capsules carries a significant risk of serotonin syndrome, a potentially fatal condition. Symptoms may include agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, fever, and coma.
Combining citalopram and Venlafaxine ER 37.5mg capsules raises serotonin levels dangerously, risking serotonin syndrome. This potentially fatal condition may manifest as agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, fever, and coma. An alternative medication is necessary.
Venlasys 37.5 Capsule ER is actively removed from the brain by P-glycoprotein, although some research indicates that this drug and its metabolite can also inhibit P-glycoprotein activity.
Extended-release Venlasys 37.5mg capsules are absorbed in the intestines following hepatic metabolism.
Venlasys 37.5 mg Extended-Release Capsules treat generalized depressive disorder. Always consult your physician before use.
Treatment with Venlasys 37.5 mg Extended-Release capsules may cause sustained blood pressure increases in some patients. Regular blood pressure monitoring is advised, with potential dose reduction or treatment discontinuation considered if necessary.
Yes, constipation is a known side effect of Venlafaxine ER 37.5mg capsules in some patients. Increase fiber intake and fluid consumption. Laxatives may also be helpful. Your doctor can advise on prevention and management. Contact your doctor if constipation persists or worsens.
Yes, Venlasys 37.5 mg Extended-Release Capsules have been associated with weight loss in some patients. Studies show this weight loss increases with higher doses and longer treatment durations. Consult your physician if this is a concern.
Venlasys 37.5 mg extended-release capsules are not considered habit-forming.
Tablets may be substituted for capsules only with a doctor's approval. Self-substitution is inadvisable, as differing formulations can affect drug release and efficacy, potentially causing adverse reactions or treatment failure.
Yes, gabapentin can be used concurrently with Venlafaxine ER 37.5mg capsules, but only under a doctor's supervision. Combined use may increase drowsiness, sleepiness, and impair concentration. Exercise caution.
Desvenlafaxine is the active form of Venlafaxine, the medication found in Venlafaxine 37.5 mg Extended-Release Capsules.
Venlasys 37.5 mg Extended-Release Capsules are not FDA-approved for fibromyalgia, although some studies suggest potential benefit. Always consult your physician before using this medication for fibromyalgia.
While not FDA-approved for nerve pain, Venlafaxine ER 37.5mg capsules demonstrate efficacy in some research studies and are used off-label for this purpose.
Venlasys 37.5 mg extended-release capsules can alter brain neurotransmitter levels, resulting in decreased appetite. This appetite suppression is dose-related.
Experience decreased sex drive or impotence? Consult your doctor; alternative medications may be available. Do not discontinue Venlasys 37.5 Capsule ER without medical supervision; abrupt cessation may worsen side effects.
Venlasys 37.5 Capsule ER
35
MRP 40
12% off